Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Oral Dexanabinol in Healthy Subjects
NCT02054754Phase 1Completed
- Sponsor
- e-therapeutics plc
- Start
- Jan 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of Dexanabinol in cancer (6 arms), sponsored by e-therapeutics plc. Primary endpoint: Safety and Tolerability Based on the Number of Participants With Adverse Events and Comparison of Baseline and Post Dose Parameters. Started Jan 2014; status: completed.
02
Drugs
Dexanabinol
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02054754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054754.